Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -36.67x is in line with its 5-year average of -35.41x, around the middle of its 5-year range (-651.10x–901.33x).
4.59% below its 12-month average of -35.06x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -63.87x.
INTEREST COVERAGE RATIO
-36.67x
INTEREST COVERAGE RATIO AVG TTM
-35.06x
INTEREST COVERAGE RATIO AVG 3Y
-30.87x
INTEREST COVERAGE RATIO AVG 5Y
-35.41x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.59%
CURRENT VS 3Y AVG
-18.80%
CURRENT VS 5Y AVG
-3.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
-771.02%
vs the sector median at left
Precision BioSciences, Inc.
Market Cap
$173.34M
Interest Coverage Ratio
-36.67x
TTM Avg
-35.06x
3Y Avg
-30.87x
5Y Avg
-35.41x
Market Cap
$171.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.95M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$177.29M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.54M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.71M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$161.12M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
Market Cap
$158.25M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $173.34M | -36.67x | -35.06x | -30.87x | -35.41x |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $169.95M | -19.95x | 6.75x | 6.75x | 6.75x |
| Cue Biopharma, Inc. (CUE)vs › | $177.29M | -74.29x | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | -709.33x | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $183.71M | -2.21x | 15.94x | 15.94x | 15.94x |
| Inogen, Inc. (INGN)vs › | $161.12M | N/A | 2247.41x | 1131.54x | 905.57x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.25M | -64.93x | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $155.04M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $154.76M | N/A | N/A | N/A | N/A |
Interest Coverage
-36.7x
Debt/Equity
0.62
Current Ratio
12.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -63.87x |
| 2026-03-31 | -29.18x |
| 2025-12-31 | 35.94x |
| 2025-09-30 | -57.09x |
| 2025-06-30 | -61.11x |
| 2025-03-31 | -62.46x |
| 2024-12-31 | -63.38x |
| 2024-09-30 | -83.11x |
| 2024-06-30 | 43.12x |
| 2024-03-31 | -7.29x |
| 2023-12-31 | -25.72x |
| 2023-09-30 | -21.46x |
| 2023-06-30 | -5.66x |
| 2023-03-31 | -25.58x |
| 2022-12-31 | -24.92x |
| 2022-09-30 | -36.24x |
| 2022-06-30 | -166.30x |
| 2022-03-31 | -651.10x |
| 2021-12-31 | -580.19x |
| 2021-09-30 | -209.85x |
| 2021-06-30 | 901.33x |
| 2019-03-31 | -107.11x |
